
    
      The study is divided into two sequential phases. The Phase I trial is a Phase Screening /
      Eligibility, which includes a screening visit, followed by 2 Visits Eligibility (3 visits).
      The Phase II study is the treatment phase randomized, double-masked that includes visits
      during therapy at Week 2, Week 6 and Month 3
    
  